Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torcetrapib/Atorvastatin vs Simvastatin in Hypercholesterolemia
NCT00267280Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Jan 2006
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of torcetrapib in hypercholesterolemia, sponsored by Pfizer. Started Jan 2006; status: terminated.
02
Drugs
torcetrapib
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00267280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00267280.